Previous studies implicated risk variants regulating SPI1 [52], a well-known microglial transcription factor shown to interact with known AD risk genes including TREM2, and CELF1 expression, with fine mapping potentially implicating CELF1 [53] from the MTCH2 locus in AD. This evidence concerns the gene TREM2 and Alzheimer disease.